NCT02737072 A Study of LY2510924 and Durvalumab in Participants With Solid Tumors Status TERMINATED Phase PHASE1
NCT02735980 A Study of Prexasertib (LY2606368) in Participants With Extensive Stage Disease Small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT02734160 A Study of Galunisertib (LY2157299) and Durvalumab (MEDI4736) in Participants With Metastatic Pancreatic Cancer Status COMPLETED Phase PHASE1
NCT02718911 A Study of LY3022855 in Combination With Durvalumab or Tremelimumab in Participants With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT02718898 A Study of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Genital Psoriasis Status COMPLETED Phase PHASE3
NCT02714569 A Study to Evaluate LY3202328 in Overweight Healthy Participants and Dyslipidemia Status COMPLETED Phase PHASE1
NCT02711553 A Study of Ramucirumab (LY3009806) or Merestinib (LY2801653) in Advanced or Metastatic Biliary Tract Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT02709486 Study of the Analgesic Efficacy and Safety of Subcutaneous Tanezumab in Subjects With Osteoarthritis of the Hip or Knee. Status COMPLETED Phase PHASE3
NCT02708095 A Study of Baricitinib (LY3009104) in Participants With Systemic Lupus Erythematosus (SLE) Status COMPLETED Phase PHASE2
NCT02703350 A Study of LY900014 in Participants With Type 1 Diabetes on Insulin Injection Therapy Status COMPLETED Phase PHASE1
NCT02703337 A Study of LY900014 in Participants With Type 2 Diabetes on Insulin Injection Therapy Status COMPLETED Phase PHASE1
NCT02703324 A Study of LY900014 Formulation in Participants With Type 1 Diabetes Mellitus Using Insulin Pumps Status COMPLETED Phase PHASE1
NCT02702011 Empa Add on to Insulin in Japanese Patient With Type 1 Diabetes Mellitus Status COMPLETED Phase PHASE2
NCT02696798 A Study of Ixekizumab (LY2439821) in TNF Inhibitor Experienced Participants With Radiographic Axial Spondyloarthritis Status COMPLETED Phase PHASE3
NCT02696785 A Study of Ixekizumab (LY2439821) in bDMARD-Naive Participants With Radiographic Axial Spondyloarthritis Status COMPLETED Phase PHASE3
NCT02693535 TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer Status RECRUITING Phase PHASE2
NCT02688712 ExIST Study of LY2157299 (Galunisertib) in Rectal Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT02688088 A Study of Abemaciclib in Participants With Cancer That is Advanced or Has Spread to Another Part(s) of the Body Status COMPLETED Phase PHASE1
NCT02683200 MRI-Guided Stereotactic Body Radiation Therapy in Treating Patients With Liver Metastases or Liver Cancer Status COMPLETED Phase EARLY_PHASE1
NCT02678182 Planning Treatment for Oesophago-gastric Cancer: a Maintenance Therapy Trial Status ACTIVE_NOT_RECRUITING Phase PHASE2